Xin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin Zhang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chunlin Wang
Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University
3 shared publications - Xin Wang
Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University
3 shared publications - Yihaoran Yang
Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University
3 shared publications - Yuliuming Wang
Department of Colorectal Cancer Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P.R. China
3 shared publications - Yunxiao Liu
Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
3 shared publications - Guiyu Wang
Department of Colorectal Tumor Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China
2 shared publications
Latest Publications
- 13 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67857
Surgical Robot-assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.
- 13 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67857
Surgical Robot-assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.
- 13 June 2025
- Published by MyJove Corporation
- No. 220,p. e67857
JoVE Video Dataset
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.
- 13 June 2025
- Published by MyJove Corporation
- No. 220,p. e67857
JoVE Video Dataset
Robot-assisted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer represents an innovative, minimally invasive surgical technique that integrates the benefits of minimally invasive surgery with natural orifice specimen extraction. In this study, a 67-year-old male patient diagnosed with sigmoid colon cancer underwent Kangduo surgical robot-assisted NOSES, with a total operative time of 290 min and an estimated intraoperative blood loss of 50 mL. The procedure involved robotic-assisted radical resection of the sigmoid colon, regional lymphadenectomy, and specimen extraction through a natural orifice. Postoperative histopathological analysis confirmed the absence of residual malignancy in the resected sigmoid colon, while 12 pericolic lymph nodes exhibited reactive hyperplasia. Both the proximal and distal surgical margins were negative for malignancy. The patient had an uneventful recovery and was discharged on postoperative day 7. The precision and flexibility of the robotic system facilitated NOSES by minimizing abdominal wall trauma, reducing postoperative complications, and shortening recovery time. This finding indicates that robot-assisted NOSES is a safe and feasible approach for the surgical treatment of sigmoid colon cancer, though further clinical experience and long-term follow-up are required to comprehensively assess its efficacy.
- Open Access
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1511-1518
Comparison of short-term outcomes of robotic-assisted radical colon cancer surgery using the Kangduo Surgical Robotic System and the Da Vinci Si Robotic System: a prospective cohort study
Background: Robotic surgery has been a revolution for colon cancer (CC) patients, with the increasing availability of different competitive robotic systems, but evidence of relevant oncologic outcomes is indeed scarce. Our goal was to compare the surgical quality and short-term oncologic outcomes of the Kangduo Surgical Robotic System and the da Vinci Si Robotic System in patients with CC. Methods: These are results from a subcohort of a multicenter randomized controlled noninferiority trial performed in three centers in China. Enrolled patients were randomly assigned to undergo surgery using either the KD-SR-01 system (KD group) or the da Vinci Si (DV) robotic system (DV group). Neither investigators nor patients were masked to treatment allocation, but assessment of pathological outcomes was masked to treatment allocation. The primary endpoint was surgical success rate. The secondary endpoints were surgical outcomes, pathologic outcomes, and postoperative outcomes. The study is registered at www.chictr.org.cn (ChiCTR2200063172). Although the long-term follow-up results were not a predefined endpoint for this study, late-stage work is in progress. Results: A total of 58 CC patients were included in this study, 28 in the KD group and 30 in the DV group. All patients were successfully operated without any intermediate open/conventional laparoscopic surgery and the success rate of surgery was 100%. Assessment of equipment docking task load and intraoperative operating sensation score were similar between the two groups. Adverse events and Clavien–Dindo grade II or higher grade complication rates were comparable between the two groups. Device arm docking time, robotic arm operation time, and intraoperative bleeding were not significantly different between the two groups. Similar results were obtained from postoperative pathological outcomes and internal environment indexes. Conclusions: The efficacy and safety of the Kangduo Robotic Surgical System has been proved, operation of the Kangduo Robotic System by experienced surgeons for CC is not less effective than the da Vinci robotic System.
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1511-1518
Open AccessComparison of short-term outcomes of robotic-assisted radical colon cancer surgery using the Kangduo Surgical Robotic System and the Da Vinci Si Robotic System: a prospective cohort study
Background: Robotic surgery has been a revolution for colon cancer (CC) patients, with the increasing availability of different competitive robotic systems, but evidence of relevant oncologic outcomes is indeed scarce. Our goal was to compare the surgical quality and short-term oncologic outcomes of the Kangduo Surgical Robotic System and the da Vinci Si Robotic System in patients with CC. Methods: These are results from a subcohort of a multicenter randomized controlled noninferiority trial performed in three centers in China. Enrolled patients were randomly assigned to undergo surgery using either the KD-SR-01 system (KD group) or the da Vinci Si (DV) robotic system (DV group). Neither investigators nor patients were masked to treatment allocation, but assessment of pathological outcomes was masked to treatment allocation. The primary endpoint was surgical success rate. The secondary endpoints were surgical outcomes, pathologic outcomes, and postoperative outcomes. The study is registered at www.chictr.org.cn (ChiCTR2200063172). Although the long-term follow-up results were not a predefined endpoint for this study, late-stage work is in progress. Results: A total of 58 CC patients were included in this study, 28 in the KD group and 30 in the DV group. All patients were successfully operated without any intermediate open/conventional laparoscopic surgery and the success rate of surgery was 100%. Assessment of equipment docking task load and intraoperative operating sensation score were similar between the two groups. Adverse events and Clavien–Dindo grade II or higher grade complication rates were comparable between the two groups. Device arm docking time, robotic arm operation time, and intraoperative bleeding were not significantly different between the two groups. Similar results were obtained from postoperative pathological outcomes and internal environment indexes. Conclusions: The efficacy and safety of the Kangduo Robotic Surgical System has been proved, operation of the Kangduo Robotic System by experienced surgeons for CC is not less effective than the da Vinci robotic System.